| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5656296 | KING PHARMS | Dual control sustained release drug delivery systems and methods for preparing same |
Aug, 2014
(9 years ago) | |
Procanbid is owned by King Pharms.
Procanbid contains Procainamide Hydrochloride.
Procanbid has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Procanbid are:
- US5656296
Procanbid was authorised for market use on 31 January, 1996.
Procanbid is available in tablet, extended release;oral dosage forms.
The generics of Procanbid are possible to be released after 12 August, 2014.
Drugs and Companies using PROCAINAMIDE HYDROCHLORIDE ingredient
Market Authorisation Date: 31 January, 1996
Treatment: NA
Dosage: TABLET, EXTENDED RELEASE;ORAL
More Information on Dosage
PROCANBID family patents
